Table 2. Indications for WCD Placement [5, 6].
| Patient populations |
| Patients with NICM and LVEF ≤ 35%, NYHA class II-III less than 3 months of GDMT |
| Patients with ICM and LVEF ≤ 35%, NYHA class II-III who cannot undergo ICD placement, within 40 days of MI or 90 days of a CABG procedure |
| Patients awaiting ICD reimplantation after device infection or dislodgement |
| Patients who are not good candidates for ICD or are not good surgical candidates |
| Patients who prefer less invasive means for SCD prophylaxis |
| Patients with a possibly reversible cause of reduced LVEF (MC, PPCM, SIC) |
| Patients with terminal HFrEF awaiting to undergo cardiac transplant in near future |
WCD: wearable cardioverter defibrillator; NICM: non-ischemic cardiomyopathy; LVEF: left ventricular ejection fraction; NYHA: New York Heart Association; GDMT: goal-directed medical therapy; ICM: ischemic cardiomyopathy; ICD: implantable cardioverter defibrillator; MI: myocardial infarction; CABG: coronary artery bypass graft surgery; SCD: sudden cardiac death; MC: myocarditis; PPCM: peripartum cardiomyopathy; SIC: stress-induced cardiomyopathy; HFrEF: heart failure with reduced ejection fraction.